
Betting on clinical trials: A father's perspective on prediction markets and his son's cancer treatment
A father shares his emotional turmoil as his 12-year-old son undergoes a clinical trial for recurring cancer, just as prediction market Kalshi moves to allow financial bets on FDA decisions and clinical trial results.
















